<DOC>
	<DOCNO>NCT02252380</DOCNO>
	<brief_summary>The propose study evaluate effectiveness ExAblate Transcranial MRgFUS tool create unilateral lesion Vim thalamus globus pallidus ( GPi ) patient treatment-refractory symptom movement disorder .</brief_summary>
	<brief_title>ExAblate Transcranial MRgFUS Management Treatment-Refractory Movement Disorders</brief_title>
	<detailed_description>The purpose study evaluate safety initial effectiveness MRI-guided focus ultrasound thermal ablation designate area brain patient suffer movement disorder symptom : - FUS MRI-guidance MRI-based thermometry safely deliver patient suffer treatment-refractory movement disorder intact human skull low risk transient adverse effect evaluate follow-up 12-months . - A pre-defined target volume inside brain accurately ablate , demonstrate post-treatment MRI . - Lesions generate ExAblate Neuro result clinical effect similar see ablative procedure use surgical technique ( e.g . RF procedure ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Hepatolenticular Degeneration</mesh_term>
	<criteria>Men woman , 18 85 year , inclusive . Subjects able willing give consent able attend study visit . A movement disorder symptom deem treatmentrefractory movement disorder neurologist , include : akathisia , akinesia , athetosis , bradykinesia , chorea , dystonia , tremor , myoclonus , dyskinesia , spasm , tic Medicationrefractoriness determine adequate dose duration standard movement disorder treatment determine specialist neurologist ( e.g . trial primidone propranolol ET ) Able communicate sensation ExAblate Neuro treatment Stable dos medication 30 day prior study entry duration study . Patients unstable cardiac status include : Unstable angina pectoris medication Patients document myocardial infarction within six month protocol entry Congestive heart failure require medication ( diuretic ) Patients antiarrhythmic drug Severe hypertension ( diastolic BP &gt; 100 medication ) Patients standard contraindication MR image nonMRI compatible implant metallic device include cardiac pacemaker , size limitation , etc . History abnormal bleeding and/or coagulopathy ( include deep venous thrombosis ) Cerebrovascular disease ( multiple CVA CVA within 6 month ) Symptoms sign increase intracranial pressure ( e.g . headache , nausea , vomit , lethargy , papilledema ) Untreated , uncontrolled sleep apnea Active suspect acute chronic uncontrolled infection History intracranial hemorrhage Individuals able willing tolerate require prolonged stationary supine position treatment Are participate participate another clinical trial last 30 day Patients unable communicate investigator staff . Presence neurodegenerative disease like multisystem atrophy , progressive supranuclear palsy , dementia Lewy body , Alzheimer 's disease . Patients history seizure within past year Patients psychiatric illness well control . Any presence psychosis exclude . Patients risk factor intraoperative postoperative bleeding ( platelet count le 100,000 per cubic millimeter ) document coagulopathy Patients brain tumor Any illness investigator 's opinion preclude participation study . Pregnancy lactation . Patient unable provide consent reason . Legal incapacity limit legal capacity . Patients DBS prior stereotactic ablation basal ganglia History immunocompromise , include patient HIV positive Known lifethreatening systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>